Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy ; volume:23 ; number:1 ; day:24 ; month:2 ; year:2023 ; pages:1-10 ; date:12.2023
Cancer imaging ; 23, Heft 1 (24.2.2023), 1-10, 12.2023
- Creator
-
Yan, Wenbin
Sun, Chunhua
Ou, Xiaomin
Hu, Chaosu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40644-023-00536-z
- URN
-
urn:nbn:de:101:1-2023070321260202557000
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yan, Wenbin
- Sun, Chunhua
- Ou, Xiaomin
- Hu, Chaosu
- SpringerLink (Online service)
Other Objects (12)
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma
Metastatic Nasopharyngeal Carcinoma: Outcome from Cancer Institute, Chennai
Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches
Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy
Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis
Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma
Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Prognostic value of pre-treatment [18F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma
Metastatic Nasopharyngeal Carcinoma: Outcome from Cancer Institute, Chennai
Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches
Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy
Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis
Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma
Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Prognostic value of pre-treatment [18F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma
Metastatic Nasopharyngeal Carcinoma: Outcome from Cancer Institute, Chennai
Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches
Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy
Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis
Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma
Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab